154 related articles for article (PubMed ID: 12352042)
1. Tumor necrosis factor-alpha and interleukin-1beta mediate endothelial permeability induced by lipopolysaccharide-stimulated whole blood.
Nooteboom A; Van Der Linden CJ; Hendriks T
Crit Care Med; 2002 Sep; 30(9):2063-8. PubMed ID: 12352042
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor-alpha and interleukin-1 beta mediate human endothelial cell activation in blood at low endotoxin concentrations.
Pugin J; Ulevitch RJ; Tobias PS
J Inflamm; 1995; 45(1):49-55. PubMed ID: 7583352
[TBL] [Abstract][Full Text] [Related]
3. Modulation of endothelial monolayer permeability induced by plasma obtained from lipopolysaccharide-stimulated whole blood.
Nooteboom A; Bleichrodt RP; Hendriks T
Clin Exp Immunol; 2006 May; 144(2):362-9. PubMed ID: 16634811
[TBL] [Abstract][Full Text] [Related]
4. Plasma obtained during human endotoxemia increases endothelial albumin permeability in vitro.
van Eijk LT; Nooteboom A; Hendriks T; Sprong T; Netea MG; Smits P; van der Hoeven JG; Pickkers P
Shock; 2006 Apr; 25(4):358-62. PubMed ID: 16670637
[TBL] [Abstract][Full Text] [Related]
5. Modulation of human endothelial cell permeability by combinations of the cytokines interleukin-1 alpha/beta, tumor necrosis factor-alpha and interferon-gamma.
Burke-Gaffney A; Keenan AK
Immunopharmacology; 1993; 25(1):1-9. PubMed ID: 8320078
[TBL] [Abstract][Full Text] [Related]
6. Cytokines regulate endotoxin stimulation of endothelial cell arginine transport.
Cendan JC; Souba WW; Copeland EM; Lind DS
Surgery; 1995 Feb; 117(2):213-9. PubMed ID: 7846628
[TBL] [Abstract][Full Text] [Related]
7. Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents.
Jagtap P; Soriano FG; Virág L; Liaudet L; Mabley J; Szabó E; Haskó G; Marton A; Lorigados CB; Gallyas F; Sümegi B; Hoyt DG; Baloglu E; VanDuzer J; Salzman AL; Southan GJ; Szabó C
Crit Care Med; 2002 May; 30(5):1071-82. PubMed ID: 12006805
[TBL] [Abstract][Full Text] [Related]
8. Can the interleukin-6 response to endotoxin be predicted? Studies of the influence of a promoter polymorphism of the interleukin-6 gene, gender, the density of the endotoxin receptor CD14, and inflammatory cytokines.
Heesen M; Bloemeke B; Heussen N; Kunz D
Crit Care Med; 2002 Mar; 30(3):664-9. PubMed ID: 11990931
[TBL] [Abstract][Full Text] [Related]
9. Endothelial permeability is increased by the supernatant of peripheral blood mononuclear cells stimulated with HLA Class II antibody.
Wakamoto S; Fujihara M; Sakagawa H; Takahashi D; Niwa K; Morioka M; Sato S; Kato T; Azuma H; Ikeda H
Transfusion; 2008 Oct; 48(10):2060-8. PubMed ID: 18564388
[TBL] [Abstract][Full Text] [Related]
10. Whole blood-mediated endothelial permeability and adhesion molecule expression: a model study into the effects of bacteria and antibiotics.
Nooteboom A; van der Linden CJ; Hendriks T
J Antimicrob Chemother; 2005 Feb; 55(2):150-6. PubMed ID: 15650003
[TBL] [Abstract][Full Text] [Related]
11. Human vascular endothelial cells produce tumor necrosis factor-alpha in response to proinflammatory cytokine stimulation.
Ranta V; Orpana A; Carpén O; Turpeinen U; Ylikorkala O; Viinikka L
Crit Care Med; 1999 Oct; 27(10):2184-7. PubMed ID: 10548204
[TBL] [Abstract][Full Text] [Related]
12. Permeability characteristics of human endothelial monolayers seeded on different extracellular matrix proteins.
Nooteboom A; Hendriks T; Ottehöller I; van der Linden CJ
Mediators Inflamm; 2000; 9(5):235-41. PubMed ID: 11200364
[TBL] [Abstract][Full Text] [Related]
13. Histamine- or vascular endothelial growth factor-induced tissue factor expression and gap formation between vascular endothelial cells are synergistically enhanced by lipopolysaccharide, tumor necrosis factor-α, interleukin (IL)-33 or IL-1β.
Kamegashira A; Yanase Y; Takahagi S; Saito R; Uchida K; Kawaguchi T; Ishii K; Tanaka A; Ozawa K; Hide M
J Dermatol; 2020 Nov; 47(11):1293-1300. PubMed ID: 32748974
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 production by human liver (myo)fibroblasts in culture. Evidence for a regulatory role of LPS, IL-1 beta and TNF alpha.
Tiggelman AM; Boers W; Linthorst C; Brand HS; Sala M; Chamuleau RA
J Hepatol; 1995 Sep; 23(3):295-306. PubMed ID: 8550994
[TBL] [Abstract][Full Text] [Related]
15. Combinations of low concentrations of cytokines and acute agonists synergize in increasing the permeability of endothelial monolayers.
Beynon HL; Haskard DO; Davies KA; Haroutunian R; Walport MJ
Clin Exp Immunol; 1993 Feb; 91(2):314-9. PubMed ID: 8428396
[TBL] [Abstract][Full Text] [Related]
16. Relative contribution of endothelial cell and polymorphonuclear neutrophil activation in their interactions in systemic inflammatory response syndrome.
Chen X; Christou NV
Arch Surg; 1996 Nov; 131(11):1148-53; discussion 1153-4. PubMed ID: 8911254
[TBL] [Abstract][Full Text] [Related]
17. Hypothermia augments polymorphonuclear leukocyte degranulation and interleukin-8 production from human umbilical vein endothelial cells and increases lipopolysaccharide-induced polymorphonuclear leukocyte-endothelial cell interaction when followed by normothermia.
Sakao Y; Nakahara Y; Carr FK; Miller EJ
J Cardiothorac Vasc Anesth; 2002 Oct; 16(5):561-6. PubMed ID: 12407606
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-alpha production in whole blood after cardiopulmonary bypass: downregulation caused by circulating cytokine-inhibitory activities.
Börgermann J; Friedrich I; Flohé S; Spillner J; Majetschak M; Kuss O; Sablotzki A; Feldt T; Reidemeister JC; Schade FU
J Thorac Cardiovasc Surg; 2002 Sep; 124(3):608-17. PubMed ID: 12202878
[TBL] [Abstract][Full Text] [Related]
19. Plasma concentrations and anti-L-cytokine effects of alpha-melanocyte stimulating hormone in septic patients.
Catania A; Cutuli M; Garofalo L; Airaghi L; Valenza F; Lipton JM; Gattinoni L
Crit Care Med; 2000 May; 28(5):1403-7. PubMed ID: 10834686
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor and interleukin 1 alpha increase vascular endothelial permeability.
Royall JA; Berkow RL; Beckman JS; Cunningham MK; Matalon S; Freeman BA
Am J Physiol; 1989 Dec; 257(6 Pt 1):L399-410. PubMed ID: 2610269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
